Selected research
Industry Research
Codeine Painkillers Industry Research Report 2026
Market perspective
The global Codeine Painkillers market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Codeine Painkillers market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Codeine Painkillers market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Codeine Painkillers market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Codeine Painkillers include TEVA, Johnson & Johnson, Novartis, Viatris, Taiji, Sanofi Aventis, Pharmaceutical Associates, Medreich and Mallinckrodt, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Codeine Painkillers market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Codeine Painkillers.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Codeine Painkillers Market by Company
TEVA
Johnson & Johnson
Novartis
Viatris
Taiji
Sanofi Aventis
Pharmaceutical Associates
Medreich
Mallinckrodt
Lannett Company
Laboratoire Riva
Hikma
Cipla
Aristo Pharma GmbH
Apotex
Codeine Painkillers Segment by Type
Single-ingredient Codeine
Multi-ingredient Medications Codeine
Codeine Painkillers Segment by Application
Narcotic Analgesic
Antitussive
Others
Codeine Painkillers Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Codeine Painkillers market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Codeine Painkillers and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Codeine Painkillers.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Codeine Painkillers companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Single-ingredient Codeine
- Multi-ingredient Medications Codeine
Applications
- Narcotic Analgesic
- Antitussive
- Others
Companies covered
- TEVA
- Johnson & Johnson
- Novartis
- Viatris
- Taiji
- Sanofi Aventis
- Pharmaceutical Associates
- Medreich
- Mallinckrodt
- Lannett Company
- Laboratoire Riva
- Hikma
- Cipla
- Aristo Pharma GmbH
- Apotex
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Codeine Painkillers by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Single-ingredient Codeine
- 2.2.3 Multi-ingredient Medications Codeine
- 2.3 Codeine Painkillers by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Narcotic Analgesic
- 2.3.3 Antitussive
- 2.3.4 Others
- 2.4 Assumptions and Limitations
3 Codeine Painkillers Breakdown Data by Type
- 3.1 Global Codeine Painkillers Historic Market Size by Type (2021-2026)
- 3.2 Global Codeine Painkillers Forecasted Market Size by Type (2027-2032)
4 Codeine Painkillers Breakdown Data by Application
- 4.1 Global Codeine Painkillers Historic Market Size by Application (2021-2026)
- 4.2 Global Codeine Painkillers Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Codeine Painkillers Market Perspective (2021-2032)
- 5.2 Global Codeine Painkillers Growth Trends by Region
- 5.2.1 Global Codeine Painkillers Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Codeine Painkillers Historic Market Size by Region (2021-2026)
- 5.2.3 Codeine Painkillers Forecasted Market Size by Region (2027-2032)
- 5.3 Codeine Painkillers Market Dynamics
- 5.3.1 Codeine Painkillers Industry Trends
- 5.3.2 Codeine Painkillers Market Drivers
- 5.3.3 Codeine Painkillers Market Challenges
- 5.3.4 Codeine Painkillers Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Codeine Painkillers Players by Revenue
- 6.1.1 Global Top Codeine Painkillers Players by Revenue (2021-2026)
- 6.1.2 Global Codeine Painkillers Revenue Market Share by Players (2021-2026)
- 6.2 Global Codeine Painkillers Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Codeine Painkillers Head Office and Area Served
- 6.4 Global Codeine Painkillers Players, Product Type & Application
- 6.5 Global Codeine Painkillers Manufacturers Established Date
- 6.6 Global Codeine Painkillers Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Codeine Painkillers Market Size (2021-2032)
- 7.2 North America Codeine Painkillers Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Codeine Painkillers Market Size by Country (2021-2026)
- 7.4 North America Codeine Painkillers Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Codeine Painkillers Market Size (2021-2032)
- 8.2 Europe Codeine Painkillers Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Codeine Painkillers Market Size by Country (2021-2026)
- 8.4 Europe Codeine Painkillers Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Codeine Painkillers Market Size (2021-2032)
- 9.2 Asia-Pacific Codeine Painkillers Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Codeine Painkillers Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Codeine Painkillers Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Codeine Painkillers Market Size (2021-2032)
- 10.2 South America Codeine Painkillers Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Codeine Painkillers Market Size by Country (2021-2026)
- 10.4 South America Codeine Painkillers Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Codeine Painkillers Market Size (2021-2032)
- 11.2 Middle East & Africa Codeine Painkillers Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Codeine Painkillers Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Codeine Painkillers Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 TEVA
- 12.1.1 TEVA Company Information
- 12.1.2 TEVA Business Overview
- 12.1.3 TEVA Revenue in Codeine Painkillers Business (2021-2026)
- 12.1.4 TEVA Codeine Painkillers Product Portfolio
- 12.1.5 TEVA Recent Developments
- 12.2 Johnson & Johnson
- 12.2.1 Johnson & Johnson Company Information
- 12.2.2 Johnson & Johnson Business Overview
- 12.2.3 Johnson & Johnson Revenue in Codeine Painkillers Business (2021-2026)
- 12.2.4 Johnson & Johnson Codeine Painkillers Product Portfolio
- 12.2.5 Johnson & Johnson Recent Developments
- 12.3 Novartis
- 12.3.1 Novartis Company Information
- 12.3.2 Novartis Business Overview
- 12.3.3 Novartis Revenue in Codeine Painkillers Business (2021-2026)
- 12.3.4 Novartis Codeine Painkillers Product Portfolio
- 12.3.5 Novartis Recent Developments
- 12.4 Viatris
- 12.4.1 Viatris Company Information
- 12.4.2 Viatris Business Overview
- 12.4.3 Viatris Revenue in Codeine Painkillers Business (2021-2026)
- 12.4.4 Viatris Codeine Painkillers Product Portfolio
- 12.4.5 Viatris Recent Developments
- 12.5 Taiji
- 12.5.1 Taiji Company Information
- 12.5.2 Taiji Business Overview
- 12.5.3 Taiji Revenue in Codeine Painkillers Business (2021-2026)
- 12.5.4 Taiji Codeine Painkillers Product Portfolio
- 12.5.5 Taiji Recent Developments
- 12.6 Sanofi Aventis
- 12.6.1 Sanofi Aventis Company Information
- 12.6.2 Sanofi Aventis Business Overview
- 12.6.3 Sanofi Aventis Revenue in Codeine Painkillers Business (2021-2026)
- 12.6.4 Sanofi Aventis Codeine Painkillers Product Portfolio
- 12.6.5 Sanofi Aventis Recent Developments
- 12.7 Pharmaceutical Associates
- 12.7.1 Pharmaceutical Associates Company Information
- 12.7.2 Pharmaceutical Associates Business Overview
- 12.7.3 Pharmaceutical Associates Revenue in Codeine Painkillers Business (2021-2026)
- 12.7.4 Pharmaceutical Associates Codeine Painkillers Product Portfolio
- 12.7.5 Pharmaceutical Associates Recent Developments
- 12.8 Medreich
- 12.8.1 Medreich Company Information
- 12.8.2 Medreich Business Overview
- 12.8.3 Medreich Revenue in Codeine Painkillers Business (2021-2026)
- 12.8.4 Medreich Codeine Painkillers Product Portfolio
- 12.8.5 Medreich Recent Developments
- 12.9 Mallinckrodt
- 12.9.1 Mallinckrodt Company Information
- 12.9.2 Mallinckrodt Business Overview
- 12.9.3 Mallinckrodt Revenue in Codeine Painkillers Business (2021-2026)
- 12.9.4 Mallinckrodt Codeine Painkillers Product Portfolio
- 12.9.5 Mallinckrodt Recent Developments
- 12.10 Lannett Company
- 12.10.1 Lannett Company Company Information
- 12.10.2 Lannett Company Business Overview
- 12.10.3 Lannett Company Revenue in Codeine Painkillers Business (2021-2026)
- 12.10.4 Lannett Company Codeine Painkillers Product Portfolio
- 12.10.5 Lannett Company Recent Developments
- 12.11 Laboratoire Riva
- 12.11.1 Laboratoire Riva Company Information
- 12.11.2 Laboratoire Riva Business Overview
- 12.11.3 Laboratoire Riva Revenue in Codeine Painkillers Business (2021-2026)
- 12.11.4 Laboratoire Riva Codeine Painkillers Product Portfolio
- 12.11.5 Laboratoire Riva Recent Developments
- 12.12 Hikma
- 12.12.1 Hikma Company Information
- 12.12.2 Hikma Business Overview
- 12.12.3 Hikma Revenue in Codeine Painkillers Business (2021-2026)
- 12.12.4 Hikma Codeine Painkillers Product Portfolio
- 12.12.5 Hikma Recent Developments
- 12.13 Cipla
- 12.13.1 Cipla Company Information
- 12.13.2 Cipla Business Overview
- 12.13.3 Cipla Revenue in Codeine Painkillers Business (2021-2026)
- 12.13.4 Cipla Codeine Painkillers Product Portfolio
- 12.13.5 Cipla Recent Developments
- 12.14 Aristo Pharma GmbH
- 12.14.1 Aristo Pharma GmbH Company Information
- 12.14.2 Aristo Pharma GmbH Business Overview
- 12.14.3 Aristo Pharma GmbH Revenue in Codeine Painkillers Business (2021-2026)
- 12.14.4 Aristo Pharma GmbH Codeine Painkillers Product Portfolio
- 12.14.5 Aristo Pharma GmbH Recent Developments
- 12.15 Apotex
- 12.15.1 Apotex Company Information
- 12.15.2 Apotex Business Overview
- 12.15.3 Apotex Revenue in Codeine Painkillers Business (2021-2026)
- 12.15.4 Apotex Codeine Painkillers Product Portfolio
- 12.15.5 Apotex Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst